annb0t
Top 20
The underwhelming share price performance of Clinuvel Pharmaceuticals Limited (ASX:CUV) in the past three years would have disappointed many shareholders. What is concerning is that despite positive EPS growth, the share price has not tracked the trend in fundamentals. The AGM coming up on the 25 October 2022 could be an opportunity for shareholders to bring these concerns to the board's attention. They could also try to influence management and firm direction through voting on resolutions such ...
>>> Read more: Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Is Looking A Bit Stretched At The Moment
>>> Read more: Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Is Looking A Bit Stretched At The Moment
